Medicare Enrolled

Dr. Manlio Goetzl, M.D.

Urology Physician · Pinehurst, NC
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
5 FIRST VILLAGE DRIVE, Pinehurst, NC 28374
9102352911
In practice since 2007 (19 years)
NPI: 1932229853 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Goetzl from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Goetzl? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Goetzl

Dr. Manlio Goetzl is an urology physician in Pinehurst, NC, with 19 years of NPI registration. Based on federal Medicare data, Dr. Goetzl performed 4,959 Medicare services across 3,398 unique beneficiaries.

Between the years covered by Open Payments, Dr. Goetzl received a total of $3,890 from 31 pharmaceutical and/or device companies across 212 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Goetzl is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 18% volume in NC $3,890 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,959
Medicare services
Top 18% in NC for urology physician
3,398
Unique beneficiaries
$47
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~261 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Urinalysis with microscopic exam
A urine test performed manually that includes examining the sample under a microscope to check for abnormalities.
915 $3 $22
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
715 $61 $241
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
499 $8 $23
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
443 $87 $344
Bladder ultrasound after voiding
An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder.
369 $7 $100
PSA test (prostate cancer screening) 284 $18 $103
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
220 $165 $733
Leuprolide acetate (for depot suspension), 7.5 mg 172 $134 $829
Abdominal X-ray, 1 view
An X-ray image of the abdomen taken from a single angle to visualize internal structures.
117 $21 $109
Basic metabolic blood panel
A blood test that measures a group of basic chemicals, including total calcium levels.
94 $8 $52
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
92 $112 $487
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
84 $8 $37
Blood creatinine level test
A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function.
83 $5 $31
Ceftriaxone antibiotic injection
This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered.
76 $0 $17
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
63 $62 $264
CT scan of abdomen and pelvis with contrast
A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures.
57 $196 $1,097
Subcutaneous or intramuscular chemotherapy injection
This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle.
56 $23 $109
Imaging of urinary tract with contrast
An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures.
51 $19 $82
Complete ultrasound of retroperitoneum
An ultrasound examination of the structures located behind the abdominal cavity.
46 $48 $325
CT scan of abdomen and pelvis, without contrast
A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye.
41 $76 $591
Routine 12-lead electrocardiogram (ECG)
A test that records the electrical activity of the heart using at least 12 leads to produce a tracing.
37 $4 $38
Cell examination with selective cellular enhancement
A laboratory test that examines cells from a specimen using a technique to selectively enhance specific cellular features for detailed analysis.
34 $21 $106
Tissue pathology examination, moderate complexity
A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This intermediate complexity procedure involves specialized techniques to identify abnormalities in the tissue.
34 $29 $234
Prostate gland biopsy
A procedure to remove small samples of tissue from the prostate gland for laboratory examination.
32 $157 $822
Transrectal ultrasound of the pelvis
An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures.
31 $105 $445
Injection, garamycin, gentamicin, up to 80 mg 30 $2 $12
Bladder irrigation and/or instillation
This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder.
29 $56 $306
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
27 $10 $50
Ureteral stent insertion via endoscope
A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder.
24 $99 $1,462
Endoscopic removal of foreign body, stone, or stent from urethra or bladder
A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item.
23 $244 $1,115
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
22 $77 $302
Electronic assessment of bladder emptying
A test that uses electronic monitoring to evaluate how well the bladder empties urine.
20 $5 $192
Ureteral stone crushing with stent insertion
An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open.
20 $316 $1,512
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
16 $135 $537
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
15 $101 $366
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
14 $39 $182
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
14 $51 $302
CT scan of abdomen and pelvis with contrast
A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas.
13 $169 $937
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
13 $37 $128
Abdominal device insertion with pressure and urine flow study
A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate.
12 $147 $704
Complex urodynamic pressure flow study
A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning.
11 $260 $1,024
Non-needle muscle activity measurement of bladder and bowel openings
This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles.
11 $25 $588
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.4% high complexity
16.7% medium
81.9% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$3,890
Total received (2018-2024)
Avg $556/year across 7 years
Top 37% in NC for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
31
Companies
212
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,782 (97.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$108 (2.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$661
2023
$527
2022
$711
2021
$876
2020
$283
2019
$370
2018
$461

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$160
Dendreon Pharmaceuticals LLC
$155
ABBVIE INC.
$114
Janssen Biotech, Inc.
$81
PROCEPT BioRobotics Corporation
$65
Boston Scientific Corporation
$48
Teleflex LLC
$20
Laborie Medical Technologies Corp.
$18
Top 3 companies account for 65.0% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$632
Dendreon Pharmaceuticals LLC
$592
Astellas Pharma US Inc
$586
Endo Pharmaceuticals Inc.
$392
Janssen Biotech, Inc.
$388
ABBVIE INC.
$258
Myovant Sciences Inc.
$149
NeoTract Inc.
$109
Sumitomo Pharma America, Inc.
$79
Boston Scientific Corporation
$77
PROCEPT BioRobotics Corporation
$65
Dornier MedTech America, Inc
$64
Olympus America Inc.
$42
AbbVie, Inc.
$42
Allergan, Inc.
$39
180 Medical, Inc.
$37
Teleflex LLC
$35
Sun Pharmaceutical Industries Inc.
$35
AbbVie Inc.
$34
Allergan Inc.
$28
Avadel Specialty Pharmaceuticals, LLC
$26
Merck Sharp & Dohme LLC
$25
UroGen Pharma, Inc.
$24
DENTSPLY IH Inc.
$23
Laborie Medical Technologies Corp.
$18
Smith+Nephew, Inc.
$18
Coloplast Corp
$17
Axonics, Inc.
$17
Progenics Pharmaceuticals, Inc.
$15
BOSTON SCIENTIFIC CORPORATION
$14
UROGEN PHARMA, INC.
$13
Top 3 companies account for 46.5% of all-time payments
Associated products mentioned in payments ›
ABIRATERONE ACETATE · AQUABEAM SYSTEM · AVEED · Androgel · Axonics · BOTOX · BOTOX THERAPEUTIC · Consumables & Accessories · ERLEADA · Erleada · GENERAL KIDNEY STONE DISEASE · GENTLECATH · GentleCath · JELMYTO · KEYTRUDA · LUPRON DEPOT · LoFric · Lupron · MYRBETRIQ · Myrbetriq · Noctiva · ORGOVYX · Olympus Laser Devices · Optilume BPH Drug Coated Balloon Catheter · PROVENGE · PYLARIFY · REZUM · STRAVIX · TITAN · TOVIAZ · UROLIFT · UroLift · UroLift System · VESICARE · XIAFLEX · XTANDI · YONSA · iTIND System · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an urology physician in Pinehurst?
Compare urology physicians in the Pinehurst area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
10
Per 100K population
9.7
County median income
$82,837
Nearest hospital
FIRSTHEALTH MOORE REGIONAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Goetzl is a clinical cardiology specialist, with above-average Medicare volume (top 18% in NC), with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Goetzl experienced with urinalysis with microscopic exam?
Based on Medicare claims data, Dr. Goetzl performed 915 urinalysis with microscopic exam services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Goetzl receive payments from pharmaceutical companies?
Yes. Dr. Goetzl received a total of $3,890 from 31 companies across 212 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Goetzl's costs compare to other urology physicians in Pinehurst?
Dr. Goetzl's average Medicare payment per service is $47. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Goetzl) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →